NIVF
NIVF
NASDAQ · Health Care

Newgenivf Group Ltd-A

$0.34
-0.22 (-38.44%)
As of Sep 28, 10:50 PM ET ·
Financial Highlights (FY 2026)
Revenue
122.02M
Net Income
255.05M
Gross Margin
20.2%
Profit Margin
209.0%
Rev Growth
—
D/E Ratio
0.16
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 20.2% 63.4% 63.4% 63.4%
Operating Margin 231.2% 15.0% 13.3% 13.3%
Profit Margin 209.0% 10.4% 12.9% 12.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 122.02M 401.7K 362.7K 344.3K
Gross Profit 24.67M 254.9K 230.1K 218.5K
Operating Income 282.11M 60.1K 48.3K 45.7K
Net Income 255.05M 41.8K 46.7K 41.5K
Gross Margin 20.2% 63.4% 63.4% 63.4%
Operating Margin 231.2% 15.0% 13.3% 13.3%
Profit Margin 209.0% 10.4% 12.9% 12.1%
Rev Growth — +17.6% -6.2% -6.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 85.7K 153.4K 184.7K 169.1K
Total Equity 524.4K 435.1K 422.0K 475.1K
D/E Ratio 0.16 0.35 0.44 0.36
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 286.97M 62.8K 66.4K 61.5K
Free Cash Flow — 54.6K 52.4K 38.3K